Supernus Pharmaceuticals (SUPN) Q3 2025 Earnings

5AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
0.37
0.64
0.9
1.17

Details

Expected EPS
0.47
Actual EPS
0.908446
Surprise EPS
0.44
Surprise Percent
+93.29%

Description

Supernus Pharmaceuticals (SUPN) has reported earnings of 0.908446 per share for Q3 2025.

0 Comments

Share your thoughts